Pharmacy tech company partners with SCPC to bolster its advocacy agenda
Published by McKnight’s LTC News
A Durham, NC-based pharmacy automation technology company is partnering with the association that represents long-term care pharmacists, lending it heft to further its advocacy agenda.
Parata announced last week that it’s becoming a Bronze Level Business Partnership with the Senior Care Pharmacy Coalition, which represents some 350 LTC pharmacies across the U.S. The company says it’s doing so because it wants to reinvest profits toward addressing the concerns of its customers, who first introduced this idea.
“We have an obligation to stay informed about issues in LTC and help any way we can. Our research proved this to be an easy decision to make. It’s a win for all involved,” Mark Longley, Parata’s executive vice president of sales and business development, said in a company announcement.
As part of the Bronze partnership, Parata says it also will take part in the coalition’s annual meeting and Business Partners Summit in July.
Senior Care Pharmacy Coalition Applauds Chairman Comer and House Oversight Committee for Shedding Light on Harmful PBM Practices, Encourages Congress to Advance PBM Reform Legislation Heard Today in House Energy and Commerce Committee Health Subcommittee
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, released a statement today regarding the House Oversight Committee’s hearing on pharmacy benefit managers.
Stuck in the middle, LTC pharmacies could be dangerously squeezed by drug price negotiations
Any lower drug prices that result from White House efforts to negotiate on behalf of Medicare beneficiaries may lead to short-term gains for nursing homes, but there also could be a steep price to pay in the long-term, experts warned this week. The Centers for Medicare & Medicaid Services on Tuesday announced the first 10 drugs covered by Medicare Part D that will be included in negotiations running through 2024. They are all commonly prescribed drugs that treat conditions ranging from diabetes to arthritis and heart failure.
Biden’s Plans to Reduce Cost of Medicare Drugs To Send Ripple Effects Through Nursing Home Industry
Following the Biden Administration’s bid this week to reduce the price of certain drugs – many of which are commonly used in nursing homes – experts are cautioning that the changes may negatively impact the bottomline of organizations in the sector. As Medicare Part D price negotiations for these drugs come into focus this week, the Senior Care Pharmacy Coalition (SCPC), for one, is warning that changes to Part D might cause “collateral damage” to long-term care pharmacies, the patients they serve and operator partners.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.